Ulcerative colitis is associated with an increased risk of venous thromboembolism in the postoperative period: The results of a matched cohort analysis

Annals of Surgery

Volumn 261, Issue 6, 2015, Pages 1160-1166

  Wilson, Matthew Z ^a   Connelly, Tara M ^a   Tinsley, Andrew ^a   Hollenbeak, Christopher S ^a   Koltun, Walter A ^a   Messaris, Evangelos ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal cancer; DVT PE; Inflammatory bowel disease; Ulcerative colitis; Venous thromboembolism

Indexed keywords

STEROID;

ADULT; ARTICLE; BENIGN TUMOR; CANCER PATIENT; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; DIVERTICULITIS; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFLAMMATORY BOWEL DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; STEROID THERAPY; SURGICAL RISK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; AGED; COHORT ANALYSIS; COLITIS, ULCERATIVE; COMPLICATION; FACTUAL DATABASE; MIDDLE AGED; PROPENSITY SCORE; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84946494275     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000788     Document Type: Article

References (29)

1. Prandoni P. Acquired risk factors of venous thromboembolism in medical patients. Pathophysiol Haemost Thromb. 2006;35:128-132.
2. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S-545S.
3. Stein PD, Matta F. Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism. Crit Care Clin. 2011;27:907-932, vii.
4. Wallaert JB, De Martino RR, Marsicovetere PS, et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum. 2012;55:1138-1144.
5. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272-2280.
6. Murthy SK, Nguyen GC. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011;106:713-718.
7. Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients. Dis Colon Rectum. 2006;49:1620-1628.
8. Reinke CE, Karakousis GC, Hadler RA, et al. Incidence of venous thromboembolism in patients undergoing surgical treatment for malignancy by type of neoplasm: an analysis of ACS-NSQIP data from 2005 to 2010. Surgery. 2012;152:186-192.
9. Monn MF, Haut ER, Lau BD, et al. Is venous thromboembolism in colorectal surgery patients preventable or inevitable? One institution's experience. J Am Coll Surg. 2013;216:395.e391-401.e391.
10. Yuhara H, Steinmaus C, Corley D, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:953-962.
11. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults:American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-523; quiz 524.
12. Merrill A, Millham F. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients. Arch Surg. 2012;147:120-124.
13. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25:5490-5505.
14. Nguyen GC. IBD: postoperative VTE prophylaxis in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:5-6.
15. Rubin DB. Matching to remove bias in observational studies. Biometrics. 1973;29:159-183.
16. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
17. Donald BR. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
18. Silber JH, Rosenbaum PR, Trudeau ME, et al. Multivariate matching and bias reduction in the surgical outcomes study. Med Care. 2001;39:1048-1064.
19. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Available at: http://ideas.repec.org/c/boc/bocode/s432001.html. Accessed November 3, 2013.
20. Guyatt GH, Eikelboom JW, Gould MK, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e185S-e194S.
21. Vedovati MC, Becattini C, Rondelli F, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259:665-669.
22. Tinsley A, Naymagon S, Enomoto LM, et al. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. J Crohns Colitis. 2013;7:e635-e640.
23. Tinsley A, Naymagon S, Trindade AJ, et al. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol. 2013;47:e1-e6.
24. Saleh T, Matta F, Yaekoub AY, et al. Risk of venous thromboembolism with inflammatory bowel disease. Clin Appl Thromb Hemost. 2011;17:254-258.
25. Wang JY, Terdiman JP, Vittinghoff E, et al. Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events. World J Gastroenterol. 2009;15:927-935.
26. Papay P, Miehsler W, Tilg H, et al. Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis. 2013;7:723-729.
27. Surgical Care Improvement Project. Perioperative management of antithrombotic therapy. Available at: http://www.jointcommission.org/assets/1/6/Perioperative Management of Antithrombotic Therapy 12 July 2012 Final.pdf. Accessed February 2014.
28. Ben-Ari Z, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol. 1997;26:554-559.
29. Scarpa M, Pilon F, Pengo V, et al. Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J Surg. 2010;34:1629-1636.